Differences in radiation-induced heart dysfunction in male versus female rats

References

• Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van 't Veer MB, Baaijens MH, de Boer JP, Hart AA, Klokman WJ, Kuenen MA, Ouwens GM, et al. 2007. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 109(5):1878–1886.
   PubMed Web of Science ®Google Scholar
• Anselmino M, De Ferrari GM, Massa R, Manca L, Tritto M, Molon G, Curnis A, Devecchi P, Sarzi Braga S, Bartesaghi G, et al. 2009. Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study. Pacing Clin Electrophysiol. 32(Suppl 1):S214–S218.
   PubMedGoogle Scholar
• Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, Kurata T, Chiappori A, Lee KH, de Wit M, et al. 2018. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N Engl J Med. 379(24):2342–2350.
   PubMed Web of Science ®Google Scholar
• Bates JE, Howell RM, Liu Q, Yasui Y, Mulrooney DA, Dhakal S, Smith SA, Leisenring WM, Indelicato DJ, Gibson TM, et al. 2019. Therapy-related cardiac risk in childhood cancer survivors: an analysis of the childhood cancer survivor study. J Clin Oncol. 37(13):1090–1101.
   PubMed Web of Science ®Google Scholar
• Bergom C, Currey A, Desai N, Tai A, Strauss JB. 2018. Deep inspiration breath hold: techniques and advantages for cardiac sparing during breast cancer irradiation. Front Oncol. 8:87.
   PubMed Web of Science ®Google Scholar
• Boerma M, Roberto KA, Hauer-Jensen M. 2008. Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiat Oncol Biol Phys. 72(1):170–177.
   PubMed Web of Science ®Google Scholar
• Boerma M, Singh P, Sridharan V, Tripathi P, Sharma S, Singh SP. 2015. Effects of local heart irradiation in a glutathione S-transferase alpha 4-null mouse model. Radiat Res. 183(6):610–619.
   PubMed Web of Science ®Google Scholar
• Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bogart J, Hu C, Forster K, Magliocco A, et al. 2015. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 16(2):187–199.
   PubMed Web of Science ®Google Scholar
• Cella L, Palma G, Deasy JO, Oh JH, Liuzzi R, D'Avino V, Conson M, Pugliese N, Picardi M, Salvatore M, et al. 2014. Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role? PLoS One. 9(10):e111753.
   PubMed Web of Science ®Google Scholar
• Cella L, D'Avino V, Palma G, Conson M, Liuzzi R, Picardi M, Pressello MC, Boboc GI, Battistini R, Donato V, et al. 2015. Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung. Radiother Oncol. 117(1):36–43.
   PubMed Web of Science ®Google Scholar
• Cella L, Oh JH, Deasy JO, Palma G, Liuzzi R, D'Avino V, Conson M, Picardi M, Salvatore M, Pacelli R. 2015. Predicting radiation-induced valvular heart damage. Acta Oncol. 54(10):1796–1804.
   PubMed Web of Science ®Google Scholar
• Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD. 2006. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 65(4):1087–1096.
   PubMed Web of Science ®Google Scholar
• Clements IP, Davis BJ, Wiseman GA. 2002. Systolic and diastolic cardiac dysfunction early after the initiation of doxorubicin therapy: significance of gender and concurrent mediastinal radiation. Nucl Med Commun. 23(6):521–527.
   PubMed Web of Science ®Google Scholar
• Cowley AW, Jr, Ryan RP, Kurth T, Skelton MM, Schock-Kusch D, Gretz N. 2013. Progression of glomerular filtration rate reduction determined in conscious Dahl salt-sensitive hypertensive rats. Hypertension. 62(1):85–90.
   PubMed Web of Science ®Google Scholar
• Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, et al. 2011. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 378(9804):1707–1716.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, Correa C, Cutter D, Gagliardi G, Gigante B, et al. 2013. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 368(11):987–998.
   PubMed Web of Science ®Google Scholar
• Desai N, Currey A, Kelly T, Bergom C. 2019. Nationwide trends in heart-sparing techniques utilized in radiation therapy for breast cancer. Adv Radiat Oncol. 4(2):246–252.
   PubMedGoogle Scholar
• Driver JA, Djousse L, Logroscino G, Gaziano JM, Kurth T. 2008. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ. 337:a2467.
   PubMed Web of Science ®Google Scholar
• Ferreira-Machado SC, Rocha NDN, Mencalha AL, De Melo LDB, Salata C, Ribeiro AF, Torres TDS, Mandarim-De-Lacerda CA, Canary PC, Peregrino AADF, et al. 2010. Up-regulation of angiotensin-converting enzyme and angiotensin II type 1 receptor in irradiated rats. Int J Radiat Biol. 86(10):880–887.
   PubMed Web of Science ®Google Scholar
• Filopei J, Frishman W. 2012. Radiation-induced heart disease. Cardiol Rev. 20(4):184–188.
   PubMed Web of Science ®Google Scholar
• Fukada J, Shigematsu N, Takeuchi H, Ohashi T, Saikawa Y, Takaishi H, Hanada T, Shiraishi Y, Kitagawa Y, Fukuda K. 2013. Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys. 87(3):487–493.
   PubMed Web of Science ®Google Scholar
• George TJ, Arnaoutakis GJ, Beaty CA, Kilic A, Baumgartner WA, Conte JV. 2012. Contemporary etiologies, risk factors, and outcomes after pericardiectomy. Ann Thorac Surg. 94(2):445–451.
   PubMed Web of Science ®Google Scholar
• Hamilton KF, Sacher GA, Grahn D. 1963. A sex difference in mouse survival under daily gamma irradiation and its modification by gonadectomy. Radiat Res. 18:12–16.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Fujiwara Y, Nomura M, Kamata M, Kojima H, Kohzai M, Sumita K, Tanigawa N. 2015. Predictive factors for pericardial effusion identified by heart dose-volume histogram analysis in oesophageal cancer patients treated with chemoradiotherapy. Br J Radiol. 88(1046):20140168.
   PubMed Web of Science ®Google Scholar
• Heron M. 2017. Deaths: leading causes for 2015. Natl Vital Stat Rep. 66(5):1–76.
   Google Scholar
• Hooning MJ, Botma A, Aleman BM, Baaijens MH, Bartelink H, Klijn JG, Taylor CW, van Leeuwen FE. 2007. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 99(5):365–375.
   PubMedGoogle Scholar
• ICRP. 2007. The 2007 recommendations of the international commission on radiological protection. Ann ICRP. 37:1–332.
   Google Scholar
• Jackson IL, Zhang Y, Bentzen SM, Hu J, Zhang A, Vujaskovic Z. 2016. Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse. Sci Rep. 6:36579.
   PubMed Web of Science ®Google Scholar
• Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B, Hung J, Garcia MJ, Kronzon I, Oh JK, et al. 2013. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 26(9):965–1012.e15.
   PubMed Web of Science ®Google Scholar
• Konski A, Li T, Christensen M, Cheng JD, Yu JQ, Crawford K, Haluszka O, Tokar J, Scott W, Meropol NJ, et al. 2012. Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiother Oncol. 104(1):72–77.
   PubMed Web of Science ®Google Scholar
• Kovalchuk O, Burke P, Besplug J, Slovack M, Filkowski J, Pogribny I. 2004. Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation. Mutat Res. 548(1–2):75–84.
   PubMed Web of Science ®Google Scholar
• Kovalchuk O, Ponton A, Filkowski J, Kovalchuk I. 2004. Dissimilar genome response to acute and chronic low-dose radiation in male and female mice. Mutat Res. 550(1–2):59–72.
   PubMed Web of Science ®Google Scholar
• Kwon DH, Halley CM, Popovic ZB, Carrigan TP, Zysek V, Setser R, Schoenhagen P, Flamm SD, Starling RC, Desai MY. 2009. Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance. Eur J Heart Fail. 11(10):937–944.
   PubMed Web of Science ®Google Scholar
• Lenarczyk M, Laiakis EC, Mattson DL, Johnson BD, Kronenberg A, North PE, Komorowski R, Mader M, Baker JE. 2020. Irradiation of the kidneys causes pathologic remodeling in the nontargeted heart: a role for the immune system. FASEB Bioadv. 2(12):705–719.
   PubMedGoogle Scholar
• Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, Orav EJ, Gelber RD, Colan SD. 1995. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med. 332(26):1738–1743.
   PubMed Web of Science ®Google Scholar
• Marinko T. 2018. Pericardial disease after breast cancer radiotherapy. Radiol Oncol. 53(1):1–5.
   PubMed Web of Science ®Google Scholar
• Marinko T, Borstnar S, Blagus R, Dolenc J, Bilban-Jakopin C. 2018. Early cardiotoxicity after adjuvant concomitant treatment with radiotherapy and trastuzumab in patients with breast cancer. Radiol Oncol. 52(2):204–212.
   PubMed Web of Science ®Google Scholar
• Marks LJ, McCarten KM, Pei Q, Friedman DL, Schwartz CL, Kelly KM. 2018. Pericardial effusion in Hodgkin lymphoma: a report from the Children’s Oncology Group AHOD0031 protocol. Blood. 132(11):1208–1211.
   PubMed Web of Science ®Google Scholar
• Martel MK, Sahijdak WM, Ten Haken RK, Kessler ML, Turrisi AT. 1998. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys. 40(1):155–161.
   PubMed Web of Science ®Google Scholar
• McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson NO, Bennet AM, Fornander T, Gigante B, Jensen MB, Peto R, et al. 2011. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol. 100(2):167–175.
   PubMed Web of Science ®Google Scholar
• McWilliam A, Kennedy J, Hodgson C, Vasquez Osorio E, Faivre-Finn C, van Herk M. 2017. Radiation dose to heart base linked with poorer survival in lung cancer patients. Eur J Cancer. 85:106–113.
   PubMed Web of Science ®Google Scholar
• Migrino RQ, Zhu X, Pajewski N, Brahmbhatt T, Hoffmann R, Zhao M. 2007. Assessment of segmental myocardial viability using regional 2-dimensional strain echocardiography. J Am Soc Echocardiogr. 20(4):342–351.
   PubMed Web of Science ®Google Scholar
• Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. 2016. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 66(4):271–289.
   PubMed Web of Science ®Google Scholar
• Moseeva MB, Azizova TV, Grigoryeva ES, Haylock R. 2014. Risks of circulatory diseases among Mayak PA workers with radiation doses estimated using the improved Mayak Worker Dosimetry System 2008. Radiat Environ Biophys. 53(2):469–477.
   PubMed Web of Science ®Google Scholar
• Moulin M, Piquereau J, Mateo P, Fortin D, Rucker-Martin C, Gressette M, Lefebvre F, Gresikova M, Solgadi A, Veksler V, et al. 2015. Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling. Circ Heart Fail. 8(1):98–108.
   PubMed Web of Science ®Google Scholar
• Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Donaldson SS, Green DM, Sklar CA, Robison LL, et al. 2009. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 339:b4606.
   PubMed Web of Science ®Google Scholar
• Ning MS, Tang L, Gomez DR, Xu T, Luo Y, Huo J, Mouhayar E, Liao Z. 2017. Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 99(1):70–79.
   PubMed Web of Science ®Google Scholar
• Ogino I, Watanabe S, Iwahashi N, Kosuge M, Sakamaki K, Kunisaki C, Kimura K. 2016. Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer. Strahlenther Onkol. 192(6):359–367.
   PubMed Web of Science ®Google Scholar
• Pogribny I, Raiche J, Slovack M, Kovalchuk O. 2004. Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes. Biochem Biophys Res Commun. 320(4):1253–1261.
   PubMed Web of Science ®Google Scholar
• Robinson CG, Samson PP, Moore KMS, Hugo GD, Knutson N, Mutic S, Goddu SM, Lang A, Cooper DH, Faddis M, et al. 2019. Phase I/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation. 139(3):313–321.
   PubMed Web of Science ®Google Scholar
• Robnett TJ, Machtay M, Vines EF, McKenna MG, Algazy KM, McKenna WG. 2000. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys. 48(1):89–94.
   PubMed Web of Science ®Google Scholar
• Sacher GA, Grahn D. 1964. Survival of mice under duration-of-life exposure to gamma rays. I. The dosage-survival relation and the lethality function. J Natl Cancer Inst. 32:277–321.
   PubMedGoogle Scholar
• Saiki H, Petersen IA, Scott CG, Bailey KR, Dunlay SM, Finley RR, Ruddy KJ, Yan E, Redfield MM. 2017. Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer. Circulation. 135(15):1388–1396.
   PubMed Web of Science ®Google Scholar
• Sardaro A, Petruzzelli MF, D'Errico MP, Grimaldi L, Pili G, Portaluri M. 2012. Radiation-induced cardiac damage in early left breast cancer patients: risk factors, biological mechanisms, radiobiology, and dosimetric constraints. Radiother Oncol. 103(2):133–142.
   PubMed Web of Science ®Google Scholar
• Schattke S, Xing Y, Lock J, Brechtel L, Schroeckh S, Spethmann S, Baumann G, Borges AC, Knebel F. 2014. Increased longitudinal contractility and diastolic function at rest in well-trained amateur Marathon runners: a speckle tracking echocardiography study. Cardiovasc Ultrasound. 12:11.
   PubMed Web of Science ®Google Scholar
• Schlaak RA, Frei A, Schottstaedt AM, Tsaih SW, Fish BL, Harmann L, Liu Q, Gasperetti T, Medhora M, North PE, et al. 2019. Mapping genetic modifiers of radiation-induced cardiotoxicity to rat chromosome 3. Am J Physiol Heart Circ Physiol. 316(6):H1267–H1280.
   PubMed Web of Science ®Google Scholar
• Schlaak RA, Frei A, Fish BL, Harmann L, Gasperetti T, Pipke JL, Sun Y, Rui H, Flister MJ, Gantner BN, et al. 2020. Acquired immunity is not essential for radiation-induced heart dysfunction but exerts a complex impact on injury. Cancers. 12(4):983.
   PubMed Web of Science ®Google Scholar
• Schlaak RA, Frei A, SenthilKumar G, Tsaih SW, Wells C, Mishra J, Flister MJ, Camara AKS, Bergom C. 2020. Differences in expression of mitochondrial complexes due to genetic variants may alter sensitivity to radiation-induced cardiac dysfunction. Front Cardiovasc Med. 7:23.
   PubMed Web of Science ®Google Scholar
• Schlaak RA, SenthilKumar G, Boerma M, Bergom C. 2020. Advances in preclinical research models of radiation-induced cardiac toxicity. Cancers. 12(2):415.
   PubMed Web of Science ®Google Scholar
• Shapiro J, van Lanschot JJB, Hulshof M, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, et al. 2015. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 16(9):1090–1098.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, Grant EJ, Sugiyama H, Sakata R, Moriwaki H, et al. 2010. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950–2003. BMJ. 340:b5349.
   PubMed Web of Science ®Google Scholar
• Snyder M, Burmeister J, Joiner M, Meyer J, Tait L, Cohen S, McSpadden E, Konski A. 2012. Potential gender differences in a normal tissue complication probability model for heart toxicity during radiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 84(3):S757–S758.
   Web of Science ®Google Scholar
• Speirs CK, DeWees TA, Rehman S, Molotievschi A, Velez MA, Mullen D, Fergus S, Trovo M, Bradley JD, Robinson CG. 2017. Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer. J Thorac Oncol. 12(2):293–301.
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. 1997. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med. 336(19):1350–1355.
   PubMed Web of Science ®Google Scholar
• Wang K, Pearlstein KA, Patchett ND, Deal AM, Mavroidis P, Jensen BC, Lipner MB, Zagar TM, Wang Y, Lee CB, et al. 2017. Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for stage III non-small-cell lung cancer. Radiother Oncol. 125(2):293–300.
   PubMed Web of Science ®Google Scholar
• Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, Komaki R, Liao Z. 2008. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys. 70(3):707–714.
   PubMed Web of Science ®Google Scholar
• Xue J, Han C, Jackson A, Hu C, Yao H, Wang W, Hayman J, Chen W, Jin J, Kalemkerian GP, et al. 2019. Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer. Radiother Oncol. 133:213–219.
   PubMed Web of Science ®Google Scholar
• Yarnold J, Brotons MC. 2010. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 97(1):149–161.
   PubMed Web of Science ®Google Scholar